HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications
Paolo Tarantino, Samuel M. Niman, Timothy K. Erick, Nolan Priedigkeit, Beth Harrison, Antonio Giordano, Faina Nakhlis, Jennifer R. Bellon, Tonia Parker, Sarah Strauß, Qingchun Jin, Tari A. King, Beth Overmoyer, Giuseppe Curigliano, Meredith M. Regan, Sara M. Tolaney, Filipa Lynce
Topics & Concepts
MedicineInternal medicineInflammatory breast cancerBreast cancerStage (stratigraphy)TrastuzumabOncologyBiomarkerImmunohistochemistryCancerGastroenterologyBiologyBiochemistryPaleontologyHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesAdvanced Breast Cancer Therapies